La
Not verified

Latus Bio, Inc.

What we write about

BiotechnologyHealthIndustriaPharmaceuticalsScienza
02/12/2025
Industria
Scienza
Biotechnology
Pharmaceuticals
Health
Children
Windows / Shopping
Latus Bio Announces IND Clearance of LTS-101 for CLN2 Disease and Receipt of Fast Track, Orphan Drug, and Rare Pediatric Disease Designations
1.00
24/02/2025
Eventi
Fairs
Industria
Health
Biotechnology
Sanità
Pharmaceuticals
Latus Bio Announces Data Presentations in Support of its Preclinical Huntington’s Disease Gene Therapy Program
1.00

Contact details

Social Media

Followers
0
Compatibility
0